Cargando…

Vaccination against Hepatitis B: A Scoping Review

OBJECTIVE: Elimination of viral hepatitis by 2030 as one of the international Sustainable Development Goals puts the hepatitis B vaccination on the forefront. However, barriers to vaccination reported in various studies are of concern. This study explores the global barriers for effective uptake of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanty, Parimala, Jena, Pratap, Patnaik, Lipilekha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046310/
https://www.ncbi.nlm.nih.gov/pubmed/33369439
http://dx.doi.org/10.31557/APJCP.2020.21.12.3453
_version_ 1783678821920145408
author Mohanty, Parimala
Jena, Pratap
Patnaik, Lipilekha
author_facet Mohanty, Parimala
Jena, Pratap
Patnaik, Lipilekha
author_sort Mohanty, Parimala
collection PubMed
description OBJECTIVE: Elimination of viral hepatitis by 2030 as one of the international Sustainable Development Goals puts the hepatitis B vaccination on the forefront. However, barriers to vaccination reported in various studies are of concern. This study explores the global barriers for effective uptake of Hepatitis-B vaccination. METHODS: A scoping review of studies reporting hepatitis B vaccination barriers was done using PMC data base and Google scholar search engine. About 803 journal articles and reports on hepatitis B barriers were retrieved but only 36 most relevant items during last 10 years were identified, pile sorted, grouped and analyze. RESULTS: Overall 74 barriers have been identified for effective uptake of hepatitis-B vaccines. Most studies focused on non-zero dose of hepatitis B vaccine, One-third of the barriers are related to system issues, one-fourth of the barriers were related to caregiver education or awareness, fear of side effect, migration etc., one-fifth barriers were related to service provider issues like poor out-reach, home visits, poor communication and/relation with the caregivers, failure to identify unimmunized children etc., and other barriers were social-cultural issues. The review reveals limited availability and accessibility to health-facility based immunization, lack of awareness among caregivers, poor communication by the healthcare workers and negative relationships with the beneficiaries, cost of vaccine in private sector, inconvenience time and place of vaccination etc. as the major barriers for hepatitis B vaccination. Barriers varied from country to country. CONCLUSION: Myriad barriers for reduced hepatitis-B vaccine uptake need to be addressed contextually as countries are at different stages of hepatitis-B vaccination implementation.
format Online
Article
Text
id pubmed-8046310
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-80463102021-04-16 Vaccination against Hepatitis B: A Scoping Review Mohanty, Parimala Jena, Pratap Patnaik, Lipilekha Asian Pac J Cancer Prev Review Article OBJECTIVE: Elimination of viral hepatitis by 2030 as one of the international Sustainable Development Goals puts the hepatitis B vaccination on the forefront. However, barriers to vaccination reported in various studies are of concern. This study explores the global barriers for effective uptake of Hepatitis-B vaccination. METHODS: A scoping review of studies reporting hepatitis B vaccination barriers was done using PMC data base and Google scholar search engine. About 803 journal articles and reports on hepatitis B barriers were retrieved but only 36 most relevant items during last 10 years were identified, pile sorted, grouped and analyze. RESULTS: Overall 74 barriers have been identified for effective uptake of hepatitis-B vaccines. Most studies focused on non-zero dose of hepatitis B vaccine, One-third of the barriers are related to system issues, one-fourth of the barriers were related to caregiver education or awareness, fear of side effect, migration etc., one-fifth barriers were related to service provider issues like poor out-reach, home visits, poor communication and/relation with the caregivers, failure to identify unimmunized children etc., and other barriers were social-cultural issues. The review reveals limited availability and accessibility to health-facility based immunization, lack of awareness among caregivers, poor communication by the healthcare workers and negative relationships with the beneficiaries, cost of vaccine in private sector, inconvenience time and place of vaccination etc. as the major barriers for hepatitis B vaccination. Barriers varied from country to country. CONCLUSION: Myriad barriers for reduced hepatitis-B vaccine uptake need to be addressed contextually as countries are at different stages of hepatitis-B vaccination implementation. West Asia Organization for Cancer Prevention 2020-12 /pmc/articles/PMC8046310/ /pubmed/33369439 http://dx.doi.org/10.31557/APJCP.2020.21.12.3453 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Mohanty, Parimala
Jena, Pratap
Patnaik, Lipilekha
Vaccination against Hepatitis B: A Scoping Review
title Vaccination against Hepatitis B: A Scoping Review
title_full Vaccination against Hepatitis B: A Scoping Review
title_fullStr Vaccination against Hepatitis B: A Scoping Review
title_full_unstemmed Vaccination against Hepatitis B: A Scoping Review
title_short Vaccination against Hepatitis B: A Scoping Review
title_sort vaccination against hepatitis b: a scoping review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046310/
https://www.ncbi.nlm.nih.gov/pubmed/33369439
http://dx.doi.org/10.31557/APJCP.2020.21.12.3453
work_keys_str_mv AT mohantyparimala vaccinationagainsthepatitisbascopingreview
AT jenapratap vaccinationagainsthepatitisbascopingreview
AT patnaiklipilekha vaccinationagainsthepatitisbascopingreview